Table 3.
Clinical significance at post-test and follow-up in both treatment and control groups.
| Study | Classification of responders | iCBT treated (n) | iCBT treated positive (post-test) | iCBT treated positive (follow-up) | Controls treated (n) | Controls treated positive (post-test) | Controls treated positive (follow-up) |
|---|---|---|---|---|---|---|---|
| 1. ⁎Allen et al. (2016) | CC, RCI | 27 | 75% | 82% | 37 | 29% | – |
| 2. ⁎Bergström et al. (2010) | CSR, RFB | 50 | 57% | 70% | 54 | 62% | 62% |
| 3. ⁎Carlbring et al. (2001) | RCI | 21 | 81% | – | 20 | 33% | – |
| 4. ⁎Carlbring et al. (2005) | CSR, RCI | 24 | 62% | 92% | 25 | 69% | 88% |
| 5. ⁎Carlbring et al. (2006) | CSR, RCI | 30 | 71% | 64% | 30 | 4% | – |
| 6. ⁎Carlbring et al. (2003) | CC, CSR | 11 | 55% | – | 11 | 37% | – |
| 7. ⁎Ciuca et al. (2018) | CC, CSR | 36 | 63% | – | 37 | 31% | – |
| 8. ⁎Fogliati et al. (2016) | RFB | 68 | 37% | 54% | 64 | 44% | 53% |
| 9. ⁎Kiropoulos et al. (2008) | CC, CSR | 46 | 33% | – | 40 | 33% | – |
| 10. ⁎Klein et al. (2009) | CC, CSR | 28 | 34% | – | 29 | 30% | – |
| 11. ⁎Klein et al. (2006) | CC, CSR | 19 | 58% | 84% | 18 | 44% | 73% |
| 12. ⁎Richards et al. (2006) | CC, CSR | 12 | 47% | 66% | 11 | 64% | 51% |
| 13. ⁎Wims et al. (2010) | CC | 29 | 70% | – | 25 | – | – |
Note: CC = clinical cutoff; CSR = clinician severity rating; RCI = Reliable Change Index; RFB = reduction from baseline.